MI Arrowhead Publishers and Conferences
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Molecular Interventions 9:125-135, (2009)
© American Society for Pharmacology and Experimental Therapeutics
10.1124/mi.9.3.6
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Valant, C.
Right arrow Articles by Christopoulos, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valant, C.
Right arrow Articles by Christopoulos, A.
Reviews

Orthosteric/Allosteric Bitopic Ligands

Going Hybrid at GPCRs

Celine Valant, Patrick M. Sexton and Arthur Christopoulos

Monash Institute of Pharmaceutical Sciences and Department of Pharmacology Monash University, Parkville, Victoria, 3052, Australia


Formula

G protein–coupled receptors (GPCRs) can adopt multiple biologically active states that can be differentially stabilized by ligands that bind to topographically distinct sites (e.g., orthosteric ligands and allosteric modulators). Recent studies in the field are now demonstrating the utility of linking orthosteric and allosteric pharmacophores to yield hybrid, or bitopic, ligands, with improved affinity and/or receptor subtype selectivity. Interestingly, this approach can also engender functional selectivity in the actions of orthosteric ligands, highlighting a viable means of further sculpting GPCR ligand responses. Indeed, some previously identified functionally selective agonists may actually represent hitherto unappreciated bitopic ligands.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics.